Fonar Corporation (FONR) Stock Analysis

Fonar Corporation (FONR) is a publicly traded company in the HEALTHCARE sector. It trades at $19.09. This page summarizes the public market data, fundamentals, and frequently asked questions for FONR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $19.09

Market Sentiment

Fonar Corporation currently has a Neutral sentiment score of 0.14.

About Fonar Corporation

Fonar Corporation (FONR) is a prominent player in the medical imaging industry, renowned for its cutting-edge advancements in Magnetic Resonance Imaging (MRI) technology aimed at enhancing disease detection and diagnosis. Headquartered in Melville, New York, Fonar is committed to innovation through ongoing clinical studies that seek to refine and elevate MRI performance, thereby improving patient care. With a strategic focus on delivering high-resolution imaging solutions, the company is pois...

GNG Research Analysis

GNG Research scores Fonar Corporation (FONR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for FONR.

Frequently Asked Questions

Does FONR pay dividends?

Fonar Corporation (FONR) does not currently pay a regular dividend.